Xilio Therapeutics
Xilio Therapeutics is a cancer Immunotherapies founded in 2016 by Rene Russo.
2
Funding Rounds
$195.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Re** Ru*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Re** Ru*** | - | - | |
| Yu** Xu | - | - | - |
| Ch******* Ro*** | - | - | - |
| Pa** J. Cl**** | - | - | - |
| To*** J. He**** | - | - | - |
| Sa** M. Bo****** | - | - | - |
| Da**** Cu**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Re** Ru*** | - | - |
Funding
Funding series
Funding Series Analysis
The company Xilio Therapeutics has raised a total of $195.5m in funding over 2 rounds.
Key Insights:
- Xilio Therapeutics, Inc. funding round, February 2021: $95m
- Xilio Therapeutics Series B round, March 2020: $100.5m
Xilio Therapeutics, Inc. funding round, February 2021
$95m
Xilio Therapeutics Series B round, March 2020
$100.5m
Industries
Xilio Therapeutics is active in the following industries:
- Engineering
- Biomedical engineering
- Biotechnology
- Technology
- Biology
- Immunotherapy
- Therapeutics